Abstract:Objective To evaluate the clinical characteristics and outcomes of patients with Gleason score 10prostate cancer treated by external radiotherapy and hormone therapy.Methods From January 2003 to March 2014, 1832 patients with prostate cancer were treated,among which 9 patients （represented 0.49%） were identified as Gleason score 10 disease on prostate corebiopsy without distant metastases when first diagnosed. All 9 patients were treated by whole pelvic externalradiotherapy （The whole pelvic dose was 50.0 Gy and the boost dose ranged from 76.2 to 78.0 Gy） andlong-term hormone therapy. We assessed the clinical characteristics, treatment outcomes and treatmenttoxicities. Survival curves were calculated using the Kaplan-Meier method.Results The median follow-up was 4.8 years. Six patients＇ pre-treatment prostate-specific antigen（PSA） levels were lower than 20.0 μg/L and three patients＇ pre-treatment PSA levels were higher than 70.0μg/L. The median percentage of positive biopsy cores was 91%. Three, four and two cases were classified asT2c, T3a and T3b stage, respectively. Three cases were assessed as N1 stage. The 5-year biochemicalfailure-free survival, distant metastasis-free survival, cancer specific survival and overall survival rates were28.6%, 57.1%, 66.7% and 57.1%, respectively. Five patients experienced grade 1-2 acute gastrointestinaltoxicities and six patients complained of grade 1-2 acute genitourinary toxicities. No bone fracture orcardiovascular disease was detected.Conclusions Gleason score 10 prostate cancer on core biopsy is usually combined with other highrisk factors. The pre-treatment PSA levels lie in two extremes. Timely and active treatments are urgent neededbecause unfavourable oncological outcomes are often presented.

Clinical application of stereotactic radiotherapy for prostate cancer

Clinical Analysis of Cyberknife Radiosurgery in the Treatment of 26 Patients with Adrenal Gland Neoplasms

Charateristic of dose distribution and its clinical application in stereotactic radiotherapy practice

The clinic therapy principle and application of stereotactic body radiotherapy for regional advanced stage non small lung cancer

The clinical report of stereotactic radiosurgery for post-operational low-grade glial tumors

Clinical Analysis of Cyberknife Stereotactic Surgery for Lung Tumors

STEREOTACTIC RADIOTHERAPY FOR 35 PATIENTS WITH PANCREATIC CANCER

Stereotactic Radiosurgery in the Treatment of Primary Central Nervous System Lymphoma.

Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials

The Clinical Effects of Boby-Gamm a Knife Radiotherapy Followed by Chem Otherapy for Local Advanced Non Small Cell Lung Cancer

[Cyberknife Stereotactic Body Radiotherapy for Liver Metastases from Prostate Cancer].

Clinical Outcomes And Prognostic Factors Of Stereotactic Body Radiation Therapy For Intrahepatic Cholangiocarcinoma

Guidelines for Radiotherapy of Prostate Cancer (2020 Edition)

The clinical application of imaging-pathology fusion guided targeted cryoablation for localized prostate cancer

Clinical Characteristics and Outcome of GleasonScore 10 Prostate Cancer on Core BiopsyTreated by External Radiotherapyand Hormone Therapy

Clinical Research of Stereotactic Biopsy in Diagnosis of Multiple Intracranial Lesions

Stereotactic Radiosurgery Combined with Chemotherapy for Primary Central Nervous System Lymphoma

Clinical observation of stereotactic body radiation therapy guided by cone beam compu-ted tomography for early non-small cell lung cancer

Clinical Observation of Plasma Kinetic Resection of Prostate Combined with Endocrine Therapy in the Treatment of Advanced Prostate Cancer with Bladder Outlet Obstruction

Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study

The Clinical Application of DSA and Xper-CT in Guiding Lung Tumor Radiofrequency Ablation Procedure